共 50 条
- [42] Comment on "Non-Proportional Hazards - an Evaluation of the MaxCombo Test in Cancer Clinical Trials" by the Cross-Pharma Non-Proportional Hazards Working Group STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (02): : 312 - 314
- [43] Testing Treatment Effect in Randomized Clinical Trials With Possible Nonproportional Hazards STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, 9 (02): : 204 - 211